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 1.  Introduction 
 Magnetic resonance imaging (MRI) is a frequently used 
radiological imaging modality that has become increasingly 
important in the diagnosis of human disease. [ 1 ] It is nonin-
vasive and versatile, does not use ionizing radiation, and can 
be acquired at high resolution for obtaining anatomical and 
functional information on soft tissues. [ 2 ] However, the low 
sensitivity inherent to MRI has led to the development of 
MRI contrast agents that increase sensitivity by catalytically 
shortening the transverse ( T 1 ) and longitudinal ( T 2 ) relaxa-
tion times of water protons. Contrast agents belong to two 
categories defi ned by those that enhance contrast in a  T 1 - or 
 T 2 -weighted MRI experiment. Whereas most  T 2 -agents are 
represented by ferromagnetic inorganic nanoparticles, [ 3 ] the 
majority of  T 1 -agents consist of small molecule paramagnetic 
complexes. [ 4 ] Among  T 1 -agents, Gd 
III contrast agents are 
most widely used in clinical MRI due to their high relaxivi-
ties (1/ T 1 ), a manifestation of the short water residence times, 
long spin relaxation times, and seven unpaired electrons 
fostered by Gd III ions. [ 4 ] Nonetheless, concerns have arisen 
regarding the release and accumulation of toxic Gd ions in 
vivo. For example, it has been reported that the administration DOI: 10.1002/smll.201502754
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of Gd-based contrast agents to patients with renal dysfunction 
may induce the severe disease, nephrogenic systemic fi brosis. [ 5 ] 
An attractive nontoxic alternative to Gd-based,  T 1 -agents 
are those that feature high-spin  d 5 Fe III metal centers which 
have been shown to have signifi cantly higher relaxivity than 
many other ions including Cu II . [ 6 ] In addition, iron-based con-
trast agents remain appealing as various small molecule Fe III 
complexes exhibit high biocompatibility and stability under 
physiological conditions. [ 7 ] Indeed, a number of iron chelates 
are proven therapeutics for the treatment of iron overload dis-
ease [ 8 ] and cancer. [ 9 ] In short, it is clear that, although effective, 
Gd-agents suffer from toxicity spurring a resurgence of interest 
in Gd-free MRI agents. Toward this goal, we have endeavored 
to explore nanoscopic materials incorporating multiple Fe III -
based chelates as  T 1 -weighted MRI contrast agents with high 
effi ciency and inherently low toxicity. 
 The strong coordination bonds between Fe III and cat-
echolic ligands have been utilized extensively by natural 
systems in a variety of functional small molecules and bio-
materials. [ 10 ] For example, the high iron affi nity observed for 
the siderophore entorbactin is provided by a  tris -catecholate 
ligand architecture. [ 11 ] Similarly, the mussel byssal cuticle 
employs 3,4-dihydroxy-L-phenylalanine (DOPA)-Fe III com-
plexes to provide strong, yet reversible crosslinking points, 
resulting in self-healing properties. [ 12 ] Interestingly, while 
small molecule iron III tris -catecholate (Fe III (catecholate) 3 ) 
complexes have been thoroughly explored as synthetic 
enterobactin mimics for iron sequestration, their potential 
to function as  T 1 -weighted MRI contrast agents has been 
largely overlooked despite their modest relaxivities. [ 13 ] 
Whereas marked improvements in the relaxivity and tar-
geting specifi city for Gd-based contrast agents has been 
achieved through the incorporation of small molecule Gd-
chelates into nanomaterial scaffolds, [ 14 ] similar advances with 
Fe III (catecholate) 3 -based materials is in its infancy. Although 
synthetic catechol-based polymers with Fe III have been 
widely described for a range of applications, [ 10,15 ] very limited 
examples have been explored as  T 1 -weighted MRI contrast 
agents. Indeed, the only system that has been studied are nat-
ural sepia melanins [ 16 ] and synthetic melanin-based materials 
in the form of polydopamines generated by oxidative poly-
merization. [ 17 ] Considering the many promising properties 
offered by poly(Fe III -catecholate) materials, including high 
stability, low toxicity, and improved relaxivity, we considered 
it timely to prepare nanostructures consisting of polycatechol 
for the development of new MRI contrast agents. 
 Current strategies for the construction of poly(Fe III -cat-
echolate) as effi cient  T 1 -weighted imaging agents for MRI 
generally focus on the complexation of natural sepia melanin 
colloidal particles with Fe III salts. [ 16,17 ] However, the develop-
ment of functional and robust contrast agents from melanin-
type materials has been met with profound challenges. Issues 
include limited control over the synthetic colloidal chemistry 
hindering size and shape control over the resulting melanin 
particles. [ 15a ] We believe that more sophisticated strategies 
making use of self-assembled soft materials from amphiphilic 
block copolymers, [ 18 ] with the integration of Fe III -catecholate 
blocks, may provide an avenue for preparing particles of 
well-defi ned and predictable morphologies. Certainly, these 
are undoubtedly critical, and highly desirable properties if 
one aims to prepare materials for in vivo use. [ 19 ] This would 
be enabled by the use of a controlled living polymerization 
method, giving rise to well-defi ned and reproducibly acces-
sible block copolymer architectures. We propose that the 
resulting supramolecular nanostructures from such copoly-
mers with rigorously controlled physical parameters (i.e., 
size, shape, and composition) would represent a new class of 
macromolecular Gd-free  T 1 -weighted MRI contrast agent. 
Control over these parameters is a must as it is widely known 
that the fundamental physical properties of nanoparticles 
may affect their behavior within biological systems. [ 20 ] In this 
work, we report our fi rst effort toward this goal through the 
design and synthesis of polycatechol-based amphiphilic block 
copolymers and the elucidation of the relaxation properties 
of the resulting self-assembled micellar nanoparticles. 
 2.  Results and Discussion 
 2.1.  Molecular Design and Micellar Nanoparticle Formation 
 Our synthetic approach employed post-polymerization 
functionalization [ 18c,d ] for the incorporation of multiple 
catechol groups localized in the middle block of a triblock 
copolymer amphiphile ( Figure  1 ). The macromolecular pre-
cursors, (OEG) m -(NHS) n -(C 6 ) p , were directly synthesized 
via ring-opening metathesis polymerization (ROMP) [ 21 ] 
(Figures S1 and S2, Supporting Information) using a modi-
fi ed 2nd generation Grubbs’ catalyst (Figure  1 a). Excess 
dopamine hydrochloride was then added to the macromo-
lecular precursors in the presence of  N , N -diisopropyleth-
ylamine (DIPEA) to afford the fi nal products. Notably, a 
post-polymerization functionalization route was taken when 
it was discovered that catechol-modifi ed norbornene mono-
mers would not polymerize utilizing this class of initiator for 
ROMP. [ 15e ] Regardless, this synthetic approach achieved a 
near quantitative incorporation of catechol groups into the 
middle region of the block copolymers as determined by the 
 1 H NMR and  13 C NMR (Figures S3–S6, Supporting Informa-
tion). Both of the resulting amphiphilic triblock copolymers 
(Polymers 1 and 2) are solids with limited solubility in non-
polar organic solvents. By varying the segment size of each 
block in the amphiphilic copolymers to tune the volume 
fraction of hydrophobic domain, two kinds of stable micellar 
morphologies (i.e., sphere and cylinder) could be obtained 
(Figure  1 b–g). 
 The assembly of resulting catechol-based amphiphilic 
block copolymers was performed in a selective solvent to 
generate the two different micelles. [ 22 ] Specifi cally, to prepare 
a spherical micellar nanoparticle ( SMN ), an aqueous solution 
of FeCl 3 (1 mg mL 
−1 ) was added at a rate of 10 µL h −1 to a 
vial containing 2 g of a stock solution of Polymer 1 in THF as 
a common solvent, with an initial concentration of 2.0 wt% 
until the fi nal water content reached 70 wt%. The stable  SMN 
were then obtained by dialyzing the micelle solution against 
deionized water for 3 d to remove the organic solvent and 
any unchelated Fe III ion. Cylindrical micellar nanoparticles 
( CMN ) were generated using Polymer 2 which consists of a 
small 2016, 12, No. 5, 668–677
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higher volume fraction of the hydrophobic domain, under 
precisely the same conditions. [ 22a ] 
 Each of the two well-defi ned micellar morphologies 
were characterized by cryo-transmission electron micros-
copy (TEM) (Figure  1 b,e) and dry state TEM (Figure S7, 
Supporting Information), demonstrating diameters for  SMN 
and  CMN of ≈30 and 25 nm, respectively. Although precise 
control over the micellar length of  CMN is not possible, [ 23 ] it 
can be clearly observed that a majority of  CMN possess long 
(>1 µm) cylindrical lengths. The presence of high contrast 
metal elements (heavy nuclei) in both  SMN and  CMN was 
evident in bright fi eld scanning transmission electron micros-
copy (BF-STEM) (Figure  1 c,f) and high angle annular dark 
fi eld (HAADF)-STEM (Figure  1 d,g). Moreover, selected area 
BF-STEM coupled with energy dispersive 
X-ray spectroscopy (EDS) confi rmed the 
presence of metal ions localized inside the 
micellar nanoparticles (Figures S8 and S9, 
Supporting Information). Specifi cally, the 
EDS profi les suggested that the content of 
Fe in the testing areas of  SMN and  CMN 
were signifi cantly higher than those on 
the grid surface background, which are in 
good agreement with the elemental map-
ping analysis results (Figures S8a and S9a, 
Supporting Information). Furthermore, 
TEM was used to confi rm that both  SMN 
and  CMN are stable in aqueous solution 
for at least six months (Figure S10, Sup-
porting Information). 
 2.2.  Relaxometric Characterization of 
Micellar Nanoparticles 
 The basic relaxation properties of  SMN 
and  CMN were fi rst investigated using 
their  1 H 1/ T 1 nuclear magnetic relaxa-
tion dispersion (NMRD) profi les acquired 
under magnetic fi eld strengths from 0.01 
to 70 MHz ( Figure  2 ). Inductively cou-
pled plasma-optical emission spectrometry 
(ICP-OES) was employed to calibrate the 
Fe concentration of  SMN and  CMN solu-
tions. The NMRD profi les show a similar 
shape and different amplitude. In both 
cases there is a poorly defi ned plateau 
at low fi elds (≈0.01–0.05 MHz), followed 
by a wide dispersion (≈0.05–7 MHz) 
and by a broad hump at higher frequen-
cies. The ratio of the relaxivity values at 
low (0.01 MHz) and high fi elds (60 MHz) 
amounts to 1.6 and 1.4 for  CMN and  SMN , 
respectively. Relaxivity,  r 1 , arises from metal-
bound and/or proximate hydrogen-bonded 
water molecules, dipolarly interacting with 
the unpaired electrons of the metal ion 
 ( )1 M 1M M 1 1
osr f T T r= × + +−  (1) 
 where  f M is the mole fraction of interacting water molecules, 
 T 1M their proton relaxation time due to the paramagnetic 
Fe III ion,  τ M the exchange lifetime, and  r 1 os the contribution 
of outer-sphere fast diffusing water protons. [ 24 ]  T 1M depends 
on  r 6 , the distance of the interacting dipoles, on the corre-
lation time ( τ C ) for the proton–electron dipolar interaction 
and on  ω I and  ω S , the proton and electron Larmor frequen-
cies, respectively. The infl ection point in the profi les refl ects 
the condition  ω S τ C = 1, so that we can estimate a value of 
≈0.4–0.6 ns for the correlation time. The appearance in both 
profi les of broad humps at high fi elds with relaxivity values 
well above 6 mM −1 s −1 represents a strong indication that the 
small 2016, 12, No. 5, 668–677
 Figure 1.  General synthetic scheme for amphiphilic triblock copolymers, and electron 
microscopy of the resulting micellar nanoparticles. a) Polymer 1: m = 38, n = 34, p = 50. 
Polymer 2: m = 20, n = 23, p = 43; b–d) Electron microscopy of  SMN formed from Polymer 
1: (b) cryo-TEM. (c) BF-STEM. (d) HAADF-STEM; e–g) Electron microscopy of  CMN formed from 
Polymer 2: (e) cryo-TEM. (f) BF-STEM. (g) HAADF-STEM.
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relaxivity is not dominated by a simple outer-sphere mech-
anism. Although this high relaxivity might originate from 
the presence of inner-sphere water interactions afforded by 
dynamic Fe III (catecholate) 2 (H 2 O) 2 moieties, we speculate the 
enhanced relaxivity may largely originate from the presence 
of one or more second-sphere interactions to a coordina-
tively saturated, six-coordinate, Fe III (catecholate) 3 , 
[ 25 ] similar 
to those observed for small molecule Fe III (catecholate) 3 com-
plexes. [ 13 ] These second-sphere interactions likely take the 
form of dynamic hydrogen bonds between H 2 O and polar 
groups on the nanoparticle proximal to Fe III (catecholate) 3 
sites, or to oxygen atoms of the Fe III (catecholate) 3 sites 
themselves. Indeed, several structurally characterized 
Fe III (catecholate) 3 complexes have been reported that fea-
ture hydrogen bonds between oxygen atoms of the FeO 6 core 
and polar H-X units (X = O, N) (see fi ve examples from Cam-
bridge Structural Database listed in Figures S11–S15, Sup-
porting Information). Moreover, direct X-ray crystallographic 
evidence for hydrogen bonding between the hydrogen atoms 
of water and the oxygen atoms of a transition-metal catecho-
late has been observed in both Ni [ 26 ] and Mn [ 27 ] complexes, 
thereby suggesting that such second-sphere H 2 O interaction 
modes are viable in these nanoparticle systems. 
 Therefore, based on this precedent, the data were fi t to 
calculate rotational correlation times of 490 and 448 ps for 
 CMN and  SMN , respectively, assuming the presence of two 
second-sphere water molecules at a long-range distance of 
3.3 ± 0.1 Å from the Fe center with a residence lifetime of 
≈2 µs [ 28 ] ( Table  1 , details of the best-fi t parameters can be 
found in the Supporting Information). These results are in 
good agreement with similar fi ndings reported for bovine 
lactoferrin [ 28 ] and methemoglobin. [ 29 ] In addition, both 
 SMN and  CMN exhibit substantially higher  r 1 than that of 
mononuclear Fe III (catecholate) 3 complexes (e.g., at a fi eld 
of 20 MHz,  r 1 values for  SMN and  CMN are 8.0 × 10 −3 and 
9.0 × 10 −3 m −1 s −1 , respectively, while  r 1 for small molecule 
Fe III (catecholate) 3 complexes are ≈2.0 × 10 −3  m −1 s −1 ), [ 13c ] indi-
cating that the macro molecular scaffolds effectively increase 
the relaxivity of contrast agent moieties by restricting the 
rotational mobility of the complex (i.e., of the vector con-
necting Fe III and the protons of second sphere water mole-
cules). [ 30 ] Moreover, the per Fe III  r 1 of  SMN and  CMN 
outperforms clinically used Gd III contrast agents across a 
wide range of applied magnetic fi eld strengths (>10 MHz) 
(see the Supporting Information). For example, measured 
enhancements over Gd-DOTA are +100% and +69% for 
 CMN and  SMN , respectively, at 1.0 T and 298 K (Figure S16, 
Supporting Information). 
 It should be noted that NMRD profi les are fi tted herein 
only in the high fi eld region because of the known limitations 
of Solomon–Bloembergen–Morgan (SBM) theory in the 
slowly rotating regime that render it unable to completely 
account for the behavior of slowly rotating systems at very 
low magnetic fi eld strengths, where the Zeeman energy is 
smaller than the zero fi eld splitting energy. [ 31 ] In addition, it is 
worth mentioning that the deviation of the profi les from the 
behavior of a well-defi ned Lorentzian might be compatible 
with the presence of different, nonequivalent Fe III ions in the 
nanoparticles. [ 13b ] The NMRD profi les may refl ect different 
structures and dynamics (number, distance, and lifetime) 
of second sphere water molecules around the Fe centers, 
which have characteristic and different electronic relaxation 
times. [ 3b ] 
 The longitudinal and transverse relaxation times ( T 1 and 
 T 2 ) of both nanoparticles, with various concentrations, at 
clinically relevant fi eld strengths ( B o = 1.41 T) were meas-
ured using time-domain NMR to quantitatively calculate 
their relaxivity values ( r 1 and  r 2 ) ( Figure  3 and Figure S17, 
Supporting Information). Both  SMN and  CMN exhibit 
high relaxivity values ( r 1, SMN  = 7.1 × 10 −3  m −1 s −1 ,  r 1, CMN  = 
7.9 × 10 −3  m −1 s −1 ) for potential clinical use (based on the cal-
culated results shown in Figure  3 a,b, Figure S17, Supporting 
Information, and  Table  2 ). [ 17a ] In summary, the excellent con-
trast enhancement of the Fe III -chelated micellar nanoparticles 
was mainly attributed to second-sphere contributions, as dis-
cussed above. Moreover, the low  r 2 / r 1 ratios of both  SMN and 
 CMN ( r 2 / r 1 = 1.25 for  SMN , and  r 2 / r 1 = 1.40 for  CMN ) favor 
positive contrast enhancement (brightening) because the 
interference from  T 2 effects (darkening) are relatively small. 
Overall, the high  T 1 relaxivity and low  r 2 / r 1 ratio of both 
micellar nanoparticles could make them 
suitable as Gd-free clinical contrast agents 
for  T 1 -weighted MRI. This conclusion is 
supported by the bright  T 1 -weighted MR 
images from  SMN and  CMN in aqueous 
solution (Figure  3 c). 
 Variable fi eld and temperature mag-
netic measurements were performed 
using a superconducting quantum inter-
ference device (SQUID) to confi rm that 
small 2016, 12, No. 5, 668–677
 Figure 2.  1 H NMRD profi les for  SMN and  CMN at 298 K.
 Table 1.  Selected relaxation parameters obtained from the analysis of NMRD profi les shown in Figure 2. 
Micelles  20 r 1 
a) 
[× 10 –3  M −1 s −1 ]
Δ 2b) 
[10 19 s −2 ]
 τ V b) 
[ps]




 q c)  τ M 
[µs]
 SMN 7.7 1.4 ± 0.1 54 ± 3 448 ± 8 3.3 ± 0.1 2 2.0 ± 0.1
 CMN 8.6 1.1 ± 0.2 50 ± 4 490 ± 12 3.3 ± 0.1 2 1.9 ± 0.2
 a) 20 MHz and 298 K;  b) The parameters for electronic relaxation are used as empirical fi tting parameters and do not have a 
real physical meaning for slowly tumbling nanosized systems. Low-fi eld data, those most affected by electronic relaxation, 
were not included in data analysis;  c) Fixed during the fi t. 
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the observed MRI contrast arises from multiple isolated 
Fe III -catecholate sites. Plots of magnetization versus applied 
magnetic fi eld show signifi cant curvature only at tempera-
tures less than 24 K, consistent with isolated paramagnetic 
iron centers ( Figure  4 ). The lack of magnetic saturation, 
even at 7 T and 2 K, indicates a signifi cant magnetic ani-
sotropy associated with the spin state and coordination 
environment of the Fe III ; however, quantitative fi tting of 
the data was not possible. This indicates that a range of 
Fe III environments may be present within  SMN and  CMN 
micelles, as suggested by the broad NMRD profi les. At 
temperatures exceeding 24 K, the magnetization is com-
pletely linear with the applied fi eld, confi rming that the 
MRI contrast ability of  SMN and  CMN results from many 
isolated Fe III -catecholate complexes inside the micellar 
nanoparticles. 
 2.3.  Long-Term Stability of Micellar Nanoparticles 
 The stability of  SMN and  CMN in serum was also examined 
in two respects: (1) No collapse or change of the micellar 
nanoparticle morphologies was observed over time; (2) The 
total metal ion content and relaxivity values of the Fe III -
chelated nanoparticles does not change signifi cantly over 
time. With regards to morphological stability, we propose 
that although many previously established micelle-based 
therapeutic systems have suffered from an inherent insta-
bility in vivo (generally undergoing collapse or break-up in 
the presence of serum lipids and proteins), [ 32 ] the micellar 
particles described here benefi t from cross-linking networks 
of individual polymer chains in the micellar interface via the 
small 2016, 12, No. 5, 668–677
 Figure 3.  MRI characterization of micellar nanoparticles. a) Plots of 1/ T 1 versus Fe 
III concentration for  SMN in different medium with calculated 
 r 1 (blue plot:  SMN in water, red plot:  SMN in freshly prepared FBS, and green plot:  SMN in FBS for 3 d); b) Plots of 1/ T 1 versus Fe 
III concentration 
for  CMN in different medium with calculated  r 1 (blue plot:  CMN in water, red plot:  CMN in freshly prepared FBS, and green plot:  CMN in FBS 
for 3 d); c)  T 1 -weighted MR images captured on a Bruker 7.0 T magnet from free Fe 
III ,  SMN and  CMN in different media ([Fe III ] is at 0.6 × 10 −3  M in 
each tube).
 Table 2.  Relaxivity data for micellar nanoparticles in different media. 
(The magnetic fi eld strength for  T 1 and  T 2 measurement is 1.41 T.)  
Micelles Media  r 1 
[× 10 −3  M −1 s −1 ]
 r 2 
[× 10 −3  M −1 s −1 ]
 r 2 / r 1 
 SMN H 2 O 7.1 8.9 1.25
 CMN H 2 O 7.9 11.1 1.40
 SMN FBS (fresh) 7.3 10.2 1.40
 CMN FBS (fresh) 7.8 10.6 1.36
 SMN FBS (3 d) 8.9 10.4 1.17
 CMN FBS (3 d) 8.8 13.3 1.51
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formation of interchain, multiple Fe III -catecholate coordina-
tion bonds. [ 12,33 ] These crosslinks lead to the particles being 
stable for more than 20 d in fetal bovine serum (FBS, 100%) 
even at a high concentration (>20 mg mL −1 ). With regards 
to the strong binding capacity and affi nity of catechols for 
Fe III , [ 10 ] we performed a stability assay of Fe III -chelated  SMN 
and  CMN in PBS solution to show that there was no iron 
release from micellar nanoparticles at different incubation 
time points (Figure S18, Supporting Information). It can be 
clearly seen that the metal ion content of  SMN and  CMN in 
PBS are ≈100% after 7 d. Accordingly, the  r 1 and  r 2 values of 
both  SMN and  CMN after 3 d incubation in FBS are almost 
identical to the ones corresponding to freshly prepared 
micellar nanoparticles (Figure  3 a,b, Figure S17, Supporting 
Information, and Table  2 ), which is in good agreement with 
that observed in  T 1 -weighted MR images (Figure  3 c). The 
very slight increase in relaxivity values of  SMN and  CMN 
might be due to interactions between nanoparticles and pro-
teins in FBS. [ 34 ] The intensity of bright MR images for several 
 SMN and  CMN samples in different media with various incu-
bation times is also found to be very similar. However, the 
MRI signal from free Fe III was observed to be immediately 
quenched in FBS (Figure  3 c), likely due to the participation 
of free ions in redox reactions in the biological fl uid. [ 35 ] This 
result also suggests that metal ions were not leaking from the 
nanoparticles after the 3 day incubation in serum, as the MR 
images do not lose intensity over that time frame (Figure  3 c). 
We conclude that the materials exhibit promising stabilities 
in biological media. 
 2.4.  Shape-Dependent MR Imaging of Micellar Nanoparticles 
in HeLa Cells 
 Prior to investigating the MR imaging performance of the 
micellar nanoparticles in HeLa cells, their cytotoxicity at 
various concentrations of Fe III was assessed using a CCK-8 
(cell counting kit-8) assay. Similar to Fe III -chelated melanin 
colloidal nanoparticles [ 17a ] and many other kinds of poly-
catechol-based biomaterials, [ 15a  ,  36 ] both  SMN and  CMN also 
show high biocompatibility and promisingly low toxicity with 
respect to live cells. Cell viability was measured in HeLa 
cells using micellar nanoparticles with various dosages from 
0.5 to 100 × 10 −6  m Fe III for 24 and 48 h incubation. Under 
these conditions, cell viability was maintained at ≈100% in all 
groups (Figure S19, Supporting Information). 
 Next,  SMN and  CMN , with identical [Fe III ] concentrations 
(67.5 × 10 −6  m ), were incubated with HeLa cells for different 
periods of time. Quantitative analysis of cellular iron uptake 
and the corresponding  T 1 relaxation values were measured 
by ICP-OES and MRI, respectively ( Figure  5 ). HeLa cells 
incubated with  SMN and  CMN exhibited enhanced positive 
contrast in  T 1 -weighted MR images compared with control 
cells (incubation times: 24 or 48 h) (Figure  5 a). Surprisingly, 
it was found that  T 1 -weighted MR images of HeLa cell pel-
lets incubated with  CMN exhibited much stronger  T 1 signal 
enhancement (shorter  T 1 relaxation time) compared with 
those incubated with  SMN after short incubation times (4 or 
12 h) (Figure  5 a). Quantitative analysis of intracellular iron 
indicated cell uptake (Figure  5 b,c) was indeed shape- and 
time-dependent (Figure  5 d). For  CMN , cell uptake signifi -
cantly increased in the fi rst 4 h, then slowed, reaching a pla-
teau at 12 h, which is in good agreement with the  T 1 values of 
each corresponding cell pellet. By contrast the intracellular 
Fe III content of  SMN gradually increased without saturation 
over a period of 48 h (Figure  5 d), matching the decreasein 
 T 1 values of the cell pellets over the incubation time. Addi-
tionally, MR imaging of  CMN- treated HeLa cells exhibits 
brighter positive contrast and shorter relaxation times than 
 SMN- treated cells at identical initial [Fe III ] concentrations 
and incubation times, particularly when short incubation 
times (i.e., 4 h) were employed. 
 In terms of mechanism, it is possible that these differ-
ences are explained by the fact that  CMN is capable of 
making multiple contacts with the cell surface providing 
an initially stronger association leading to faster and more 
effi cient uptake. Indeed, in this context it is important to 
note that various observations have been made concerning 
shape-dependent polymeric nanoparticle cell internalizati
on. [ 20b  ,  37 ] However, general trends and mechanisms are yet 
to be elucidated, as uptake effi ciencies vary by nanoparticle 
composition, fl exibility, surface charge, overall dimensions 
and aspect ratio, and other confounding factors. [ 20b  ,  37,38 ] In 
this study, poly(Fe III -catecholate)-based nanoparticles were 
internalized into HeLa cells to a higher extent when they 
small 2016, 12, No. 5, 668–677
 Figure 4.  Magnetization data collected as a function of applied fi eld for 
a)  SMN and b)  CMN from 2 to 300 K.
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were of a cylindrical morphology than when they were in the 
form of spherical particles (Figure  5 b,c). A similar trend was 
also reported for shell-crosslinked spherical and cylindrical 
micelles, [ 39 ] as well as polymer brush-based spherical and long 
rod-like nanostructures. [ 38 ] Considering that shape not only 
plays an important role in cell internalization, but can also be 
a determining factor in overall biodistribution patterns in vivo 
(i.e., blood circulation and extravasation), [ 20a  ,  38 ] these prelimi-
nary results introduce exciting opportunities for optimization 
and tunability in the design of self-assembled nanoparticles. 
This highlights the power of the approach for the preparation 
of nanoparticles from well-defi ned polymers generated uti-
lizing a living polymerization. Indeed, as a demon stration of 
this concept, the approach taken here provides direct access 
to two well-defi ned morphologies of poly-
catechol-based nanoparticle, not easily 
achievable utilizing analogous synthetic 
melanin colloidal nanoparticles prepared 
by oxidative polymerization. 
 3.  Conclusion 
 In summary, we have developed a new 
class of effi cient and biocompatible MRI 
contrast agents based on micellar nanopar-
ticles formed from amphiphilic poly(Fe III -
catecholate)-based copolymers. Compared 
with recently reported natural or synthetic 
melanin-based  T 1 agents, our approach uti-
lizes well-defi ned triblock copolymers pre-
pared via a controlled living polymerization 
method. This synthetic route gives access to 
a tunable polymer system and hence, differ-
ently shaped self-assembled nanoparticles 
with controlled physical parameters. These 
nanoparticles have the potential to be used 
for various applications in diagnostic radi-
ology and imaging, due to their enhanced 
relaxivity, and long-term stability in biological 
media. Moreover, we further demonstrate 
that the resulting nano particles provide 
enhanced positive contrast for MR imaging 
in HeLa cells. Notably, we observed shape-
dependent behavior in terms of cellular 
uptake with cylindrical micelles exhibiting 
brighter contrast and shorter relaxation 
times than the analogous spherical micelles. 
We present this study with the goal that it 
stimulates further investigation of polycat-
echol nanoparticles in terms of their poten-
tial as Gd-free MRI contrast agents. Work 
in our own laboratory on shape-dependent 
behavior in vivo is underway with respect 
to both intraperitoneal and intravenous 
delivery of polycatechol nanoparticle-based 
contrast agents. 
 4.  Experimental Section 
 Monomer and Polymer Synthesis and Characterization : All 
chemicals were purchased from commercial sources and used 
without further purifi cation, unless otherwise indicated. Anhy-
drous toluene and dichloromethane were purifi ed using a Dow-
Grubbs two-column purifi cation system (Glasscontour System, 
Irvine, CA). [ 40 ] (IMesH 2 )(C 5 H 5 N) 2 (Cl) 2 Ru = CHPh was prepared as 
described by Sanford et al. [ 41 ] Monomers  1 ,  2 ,  3 were synthesized 
as previously reported. [ 18a  ,  42 ] Polymerizations were performed 
under a dry dinitrogen atmosphere with anhydrous, degassed sol-
vents in a glove box. 
 1 H (400 MHz) and  13 C (100 MHz) NMR spectra were recorded 
on a Varian Mercury Plus spectrometer. Chemical shifts ( 1 H) are 
small 2016, 12, No. 5, 668–677
 Figure 5.  a) In vitro  T 1 -weighted MR images of HeLa cells incubated with  SMN and  CMN ([Fe 
III ] 
is 67.5 × 10 −6  M ) for different periods of time; TEM image of b)  SMN and c)  CMN , trapped inside 
vesicles of HeLa cells (see Figure S20 of the Supporting Information for additional cellular TEM 
images); d) Quantitative determination of intracellular Fe III content (per 10 6 cells) for HeLa 
cells incubated with  SMN and  CMN for different periods of time and their corresponding  T 1 
relaxation values.
www.MaterialsViews.com
675© 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.small-journal.com
reported in δ (ppm) relative to the C 5 D 5 N residual proton peaks 
(δ 7.22, δ 7.58, and δ 8.74 ppm). Chemical shifts ( 13 C) are reported 
in δ (ppm) relative to the C 5 D 5 N carbon peaks (δ 123.87, δ 135.91, 
and δ 150.35 ppm). All  13 C NMR spectra were proton decoupled. 
Mass spectra were obtained at the UCSD Chemistry and Biochem-
istry Molecular Mass Spectrometry Facility. Polymer dispersities 
and molecular weights were determined by size-exclusion chroma-
tography (Phenomenex Phenogel 5 µ 10, 1 K-75 K, 300 × 7.80 mm 
in series with a Phenomex Phenogel 5 µ 10, 10 K-1000 K, 300 × 
7.80 mm (0.05  M LiBr in DMF) using a Shimatzu pump equipped 
with a multiangle light scattering detector (DAWN-HELIOS: Wyatt 
Technology) and a refractive index detector (Optilab T-rEX: Wyatt 
Technology) normalized to a 30 000 MW polystyrene standard 
using dn/dc of 0.100 for all the polymers. 
 Micelles Preparation and Characterization : The samples were 
fi rst dissolved in THF as the common solvent and stirred at room 
temperature overnight to ensure complete dissolution of the 
polymer to prepare a stock solution with an initial concentration 
of 2 wt%. The solution was then fi ltered through a fi lter of 0.22 µm 
pore size to remove any dust. FeCl 3 solution (1 mg mL 
−1 ) was fi l-
tered through a fi lter of 0.22 µm pore size and added dropwise 
at a rate of 10 µL h −1 using a syringe pump into a vial containing 
2.00 g of the stock solution. FeCl 3 solution addition was continued 
until reaching a fi nal water content of 70 (wt)%. Then the micelle 
solution was dialyzed against deionized water for 3 d to remove 
the common solvent, excess Fe III and fi x the micellar morphology. 
 Snakeskin dialysis tubing was purchased from Thermoscien-
tifi c, Inc. with a molecular weight cut off (MWCO) of 10 000 g mol −1 . 
TEM was performed on a FEI Sphera microscope operating at 
200 keV. TEM grids were prepared by depositing small (3.5 µL) ali-
quots of sample onto grids (≈2 min, Formvar stabilized with carbon 
(5–10 nm) on 400 copper mesh, Ted Pella Inc.) that had previ-
ously been glow discharged using an Emitech K350 glow discharge 
unit and plasma-cleaned for 90 s in an E.A. Fischione 1020 unit. 
Images were recorded on a 2 K X 2 K Gatan CCD camera. 
 Cryo-TEM experiments were also performed on a FEI Sphera 
microscope operating at 200 keV. TEM grids were prepared by 
depositing small (3.5 µL) aliquots of sample onto grids (Quanti-
foil R2/2 holey carbon) that had previously been glow discharged 
using an Emitech K350 glow discharge unit and plasma-cleaned 
for 90 s in an E.A. Fischione 1020 unit. Sample was loaded onto 
the grids at 4 °C, blotted with fi lter paper to create a thin fi lm on 
the grid, then plunged into liquid ethane and transferred into a 
precooled Gatan 626 cryo-transfer holder, which maintained the 
specimen at liquid-nitrogen temperature in a FEI Sphera micro-
scope operated at 200 keV. Images were recorded on a 2 × 2 K 
Gatan CCD camera. 
 STEM and STEM-EDS analysis were acquired on a JEOL JEM 
2100F TEM equipped with an INCA (Oxford) EDS detector at 
the NanoScale Fabrication and Characterization Facility (NFCF), 
Peterson Institute of Nanoscience and Engineering (PINSE), Uni-
versity of Pittsburgh, PA. Samples were prepared by drop-casting 
5 µL of sample onto TEM grids (ultrathin 5 nm A-type carbon with 
400 mesh copper, Ted Pella, Inc.) followed by slow drying covered 
on the bench top for at least 3 h. Samples were then dried under 
vacuum for 24–48 h to remove contamination that would interfere 
with STEM-EDS. Grids were loaded into a JEOL 31640 beryllium 
double tilt holder. STEM-EDS data were collected for 180–600 s 
at specifi c points, using the largest probe size (1.5 nm electron 
beam diameter) with a 200 kV accelerating voltage. Images were 
collected in bright fi eld (BF) and high-angle annular dark fi eld 
(HAADF) modes. 
 The magnetic properties of micellar nanoparticles were char-
acterized using a Quantum Design MPMS3 superconducting 
quantum interference device (SQUID) with a maximum fi eld of 7 T. 
Freeze-drying solid samples (≈10 mg) were packed into standard 
Quantum Design plastic sample holders. Magnetization data were 
collected in DC mode and corrected for diamagnetic contributions 
using Pascal’s constants. 
 Fe III Concentration Determination in Micelles : In order to deter-
mine Fe III concentration, the metal was fi rst stripped from the poly-
mers using the following procedure. To an aliquot of each sample 
(100 µL) was added 1% HNO 3 in water (1900 µL). Each mixture 
was then stirring for about 12 h. Then the Fe III concentration was 
quantifi ed by inductively coupled plasma-optical emission spec-
trometry (ICP-OES) using a Perkin Elmer Optima 3000DV spec-
trometer in the Scripps Institution of Oceanography, University of 
California, San Diego. 
 Fe III Stability in PBS : To determine the stability of Fe III chelated 
in  SMN and  CMN , we redispersed these two types of micellar 
nanoparticles in PBS (pH = 7.4). 300 µL of SMN and CMN solu-
tion (three replicates) were added in 500 µL dialysis tubes with 
 M w = 3500, respectively, and dialyzed to 500 mL PBS (pH = 7.4) 
under room temperature with magnetic stirring. 20 µL  SMN and 
 CMN aliquots were taken at time points as 8 h, 24 h, 48 h, 72 h, 
7 d for ICP-OES analysis. 
 Determination of the In Vitro Stability of Micelles in FBS by MRI 
Analysis : Samples of both  SMN and  CMN were prepared in FBS 
at various [Fe III ] concentrations (For  SMN , 5 [Fe III ] concentrations 
were used: 0.6 × 10 −3  M , 0.3 × 10 −3 , 0.15 × 10 −3 , 0.075 × 10 −3 , 
and 0.038 × 10 −3  M ; while for  CMN , 5 [Fe III ] concentrations were 
used: 0.67 × 10 −3 , 0.34 × 10 −3 , 0.17 × 10 −3 , 0.08 × 10 −3 , and 
0.04 × 10 −3  M ) 3 d prior to MRI analysis, and as controls, samples 
of identical concentration to the latter were prepared in both FBS 
and water immediately before MRI analysis (named,  SMN / CMN in 
FBS for 3 d,  SMN / CMN in freshly prepraed FBS, and  SMN / CMN in 
water, respectively). Longitudinal and transverse relaxation time 
( T 1 and  T 2 ) measurements were acquired with a Bruker Minispec 
mq60 (1.41 T or 60 MHz, 37 °C). Relaxivities ( r 1 and  r 2 ) were cal-
culated by linearly fi tting plots of 1/ T 1 (s 
−1 ) or 1/ T 2 (s 
−1 ) versus Fe III 
ions concentrations (µM). MR images were acquired on a Bruker 
7.0 T magnet equipped with Avance II hardware and a 72 mm 
quadrature transmit/receive coil ([Fe III ] = 0.6 mM in each tube). 
 T 1 contrast was determined by selecting regions of interest 
(ROI) using the ParaVision Version 5.1 software. The fi tting 
parameters for 7 T MRI analysis are as follows: TR = 750.0 ms, 
TE = 12.6 ms, echo = 1/1, FOV = 6.91/3.12 cm, slice thickness = 2 mm, 
nex = 2 mm, matrix = 256*116. 
 1 H NMRD Profi les : Proton 1/ T 1 NMRD profi les were measured 
on a fast fi eld-cycling Stelar SMARTracer Relaxometer (Stelar, 
Mede (PV), Italy) at magnetic fi eld strengths from 0.00024 to 
0.25 T (corresponding to 0.01–10 MHz proton Larmor frequencies) 
at room temperature. The relaxometer operates under computer 
control with an absolute uncertainty in 1/ T 1 of ±1%. Additional 
data points in the range 15–70 MHz were obtained on a Bruker 
WP80 NMR electromagnet adapted to variable-fi eld measurements 
(15–80 MHz proton Larmor frequency) Stelar Relaxometer. The 
 1 H  T 1 relaxation times were acquired by the standard inversion 
small 2016, 12, No. 5, 668–677
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recovery method with typical 90° pulse width of 3.5 µs, 16 experi-
ments of 4 scans. The temperature was controlled with a Stelar 
VTC-91 airfl ow heater equipped with a calibrated copper-con-
stantan thermocouple (uncertainty of ± 0.1 °C). 
 Cell Viability : In vitro cytotoxicity of micellar nanoparticles was 
determined in HeLa cells by the CCK-8 (cell counting kit-8) assay. 
HeLa cells were incubated on 96-well plates with 1 × 10 4 cells per 
well in High-glucose DMEM medium containing 10% fetal bovine 
serum and 1% antibiotics at 37 °C in 5% CO 2 humidifi ed atmos-
phere for 24 and 48 h respectively. Addition of 10 µL of CCK-8 solu-
tion to each well and incubation for another 4 h at 37 °C resulted 
in the formation of formazan crystals. Then the absorbance value 
at 460 nm was recorded using a microplate reader. The absorb-
ance value of the untreated cells was used as the reference value 
of 100% cellular viability. 
 Shape- and Time-Dependent MR Imaging in HeLa cells : HeLa 
cells were seeded in 15 cm round tissue culture dishes and allowed 
to attach overnight. After washing twice with sterile PBS, the cells 
were incubated with micellar nanoparticles (the concentration of 
Fe III ions was ≈67.5 × 10 −6  M ) for different times including 4, 12, 24, 
and 48 h, respectively, at normal cell culture condition. The cells 
were washed with PBS three times in order to remove excess nano-
particles, and then treated with 0.05% trypsin to remove them 
from the dishes. The cells were gathered by centrifuge at 300 g 
for 3 min and washed with PBS buffer twice. The number of cells 
in each sample was counted for further use. The cell MR images 
were acquired on a Bruker 7.0 T magnet with Avance II hardware 
equipped with a 72 mm quadrature transmit/receive coil.  T 1 con-
trast was determined by selecting regions of interest (ROI) using 
Software ParaVision Version 5.1. The parameters for 7 T MRI are: 
TR = 1000.0 ms, TE = 12.6 ms, echo length = 1, FOV = 7.91/3.22 cm, 
slice thickness = 1 mm, nex = 1 mm, matrix = 256*104. Then, the 
cells were digested by 70% HNO 3 solution under bath sonication 
for overnight, in order to test the iron ions content by ICP-MS. The 
Fe III quantities of each samples were normalized to 10 6 cells. 
 Cell TEM Observation : HeLa cells were seeded in 35 mm round 
tissue culture dishes and allowed to proliferate till 80% fl uent. 
After washing twice with sterile PBS buffer, the cells were incu-
bated with micellar nanoparticles (the concentration of Fe III ions 
were ≈67.5 × 10 −6  M ) for 24 h at 37 °C. The cells were washed with 
PBS three times in order to remove excess nanoparticles, and then 
were fi xed by 2% glutaraldehyde in 0.1  M sodium cacodylate buffer 
with pH = 7.4 (SC buffer) on ice for more than 2 h. After washing 
three times with 0.1  M SC buffer for 5 min each, the cells were post-
fi xed with 1% osmium tetroxide in 0.1  M SC buffer for 1 h on ice. 
Then cell pellets were washed with 0.1  M SC buffer three times for 
5 min, followed by a quick rinse with H 2 O. The cell pellets were 
stained with 2% uranyl acetate (UA) for 1 h on ice. After staining, 
they were dehydrated in a graded series of ethanol (50%, 70%, 
90%, and 100%) for 5–8 min each, and dried in acetone at room 
temperature. Then the cell pellets were infi ltrated by 50:50 dry 
acetone/durcupan for 1–2 h on a rotator, followed by 100% dur-
cupan overnight and 2X 100% durcupan next day. Finally, the cell 
pellets were embedded in durcupan and incubated in an oven at 
60 °C for 36–48 h. Ultrathin sections were cut and were examined 
via electron microscopy. 
 NMRD Profi les Analysis : A simplifi ed model was utilized to 
analyze the data and obtain an estimation for some of the rele-
vant molecular parameters affecting the relaxivity of the system. 
In this model, only the high fi eld data were considered and the fi t 
was performed according to the Solomon–Bloembergen–Morgan 
(SBM) set of equations, as discussed in the main text. The deter-
mination of electron spin relaxation parameters is almost entirely 
dependent upon fi tting the low fi eld data. As we stated in the 
manuscript, low fi eld data were not included in the fi tting. The 
reason for this is simply that SBM theory does not function very 
well across this frequency range for slowly tumbling systems—
a fact that has been commonly noted for many years by several 
different groups. [ 31 ] For this reason it would be unwise to try to 
attribute any genuine physical meaning to the values of Δ 2 and 
 τ V . We then used as adjustable parameters Δ 2 ,  τ V ,  τ R ,  τ M , and 
 q / r 6 . Satisfactory fi t was obtained with the parameters reported 
in Table  1 . The choice of  q = 2 is arbitrary and was made since 
associated with the reasonable value of  r of 3.3 Å. Of course, set-
ting  q = 3 we would obtain values for  r equal to 3.72 Å. The same 
value was reported in the case of Fe III heme-HSA. [ 43 ] A distance of 
3.2 ± 0.1 Å was also reported for bovine lactoferrin. [ 28 ] The value 
of the rotational correlation times is much shorter than that associ-
ated with a macromolecular system and in good agreement with 
that expected for loosely bound second-sphere water molecules. 
The exchange lifetime  τ M is also very similar to that estimated for 
bovine lactoferrin. [ 28 ] 
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